These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36093880)

  • 1. Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis,
    Saad MH; El-Moselhy TF; S El-Din N; Mehany ABM; Belal A; Abourehab MAS; Tawfik HO; El-Hamamsy MH
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2489-2511. PubMed ID: 36093880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical studies on 1,4-dihydropyridine derivatives as P-glycoprotein allosteric inhibitors: insights on symmetry and stereochemistry.
    Mollazadeh S; Hadizadeh F; Ferreira RJ
    J Biomol Struct Dyn; 2021 Aug; 39(13):4752-4763. PubMed ID: 32573349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors.
    Mansour B; Bayoumi WA; El-Sayed MA; Abouzeid LA; Massoud MAM
    Chem Biol Drug Des; 2022 Jul; 100(1):121-135. PubMed ID: 35501997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
    Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
    Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting ageless antiques; synthesis, biological evaluation, docking simulation and mechanistic insights of 1,4-Dihydropyridines as anticancer agents.
    Sidhom PA; El-Bastawissy E; Salama AA; El-Moselhy TF
    Bioorg Chem; 2021 Sep; 114():105054. PubMed ID: 34146919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.
    Mollazadeh S; Shamsara J; Iman M; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017; 12(2):174-185. PubMed ID: 28137213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
    Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
    Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity.
    Foroughinia F; Javidnia K; Amirghofran Z; Mehdipour A; Miri R
    J Pharm Pharmacol; 2008 Nov; 60(11):1481-9. PubMed ID: 18957169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
    Kaczor A; Nové M; Kincses A; Spengler G; Szymańska E; Latacz G; Handzlik J
    Molecules; 2020 May; 25(9):. PubMed ID: 32403277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes.
    Mohamed MF; Ibrahim NS; Elwahy AHM; Abdelhamid IA
    Anticancer Agents Med Chem; 2018; 18(15):2156-2168. PubMed ID: 30338746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
    El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH
    Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent.
    Mollazadeh S; Moosavi F; Hadizadeh F; Seifi M; Behravan J; Iman M
    Recent Pat Anticancer Drug Discov; 2018; 13(2):255-264. PubMed ID: 29468983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
    Alkamaly OM; Altwaijry N; Sabour R; Harras MF
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000351. PubMed ID: 33252142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
    Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
    Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.